Plasma cell myeloma producing IgG, IgM, and IgA immunoglobulins in a cow

Mamoru Kameyama1, Yoshiharu Ishikawa, Tomoyuki Shibahara

  • 1Himeji Livestock Hygiene Service Center, 2-10-16 Taderahigashi, Himeji 670-0081, Japan.

Insights

Plasma cell myeloma in a cow caused continuous nosebleeds and emaciation. The cancer infiltrated lymph nodes, spleen, bone marrow, and kidneys, with amyloid deposits also present.

Area of Science:

  • Veterinary Pathology
  • Oncology
  • Immunology

Background:

  • Plasma cell myeloma is a rare malignancy of terminally differentiated B lymphocytes (plasma cells).
  • This case investigates a rare occurrence of plasma cell myeloma in a bovine patient.

Observation:

  • A 6-year-old Holstein cow presented with persistent epistaxis, progressive weight loss, and hyperglobulinemia.
  • Necropsy revealed enlarged caudal mesenteric lymph nodes, with neoplastic plasma cell infiltration observed in lymph nodes, spleen, bone marrow, and kidneys.
  • Amyloid-like material, Congo red-negative in lymph nodes and Congo red-positive in spleen, kidneys, liver, and adrenal glands, was detected.

Findings:

  • Immunohistochemistry confirmed neoplastic plasma cells expressed lambda light chains and three heavy chain classes, but not kappa light chains.
  • Nonamyloid deposits stained positive for lambda light chains and heavy chains.
  • Plasmacytoid cells positive for IgG, IgM, or IgA were present within the lesions, suggesting potential immunoglobulin class switching.

Implications:

  • This case highlights the potential for plasma cell myeloma to manifest with diverse clinical signs and pathological findings in cattle.
  • The presence of both amyloid and nonamyloid deposits, along with multi-immunoglobulin expression, provides insights into the complex pathophysiology of bovine myeloma.
  • Understanding these mechanisms can aid in the diagnosis and management of similar cases in veterinary oncology.

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Antibody Structure and Classes01:25

Antibody Structure and Classes

Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.